Back to search

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Data up to Jan 2025

Published2010
Citations672
References35
Clinical Trials (1)

Total Citations Per Year

Abstract

References (35)

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

2003 • 25,662 citations

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

2008 • 3,396 citations

The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

2004 • 2,991 citations

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

2002 • 1,778 citations

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

2002 • 1,556 citations

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

2008 • 1,539 citations

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

2006 • 1,440 citations

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

2008 • 1,098 citations

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

2003 • 930 citations

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

2006 • 890 citations

[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].

2008 • 624 citations

Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure

2004 • 599 citations

Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women1

2001 • 596 citations

Avosentan for Overt Diabetic Nephropathy

2010 • 454 citations

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

2005 • 371 citations

Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan

2008 • 351 citations

Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease

2008 • 324 citations

Renoprotective role of the vitamin D receptor in diabetic nephropathy

2007 • 296 citations

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy

2007 • 293 citations

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase

2008 • 285 citations

Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy

2006 • 283 citations

Retarding progression of chronic renal disease: The neglected issue of residual proteinuria

2003 • 268 citations

Suppression of renin–angiotensin gene expression in the kidney by paricalcitol

2008 • 262 citations

Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1998 • 248 citations

Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB Signaling

2008 • 247 citations

Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD

2006 • 224 citations

Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats

2007 • 196 citations

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

2009 • 188 citations

Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D3 ) for the treatment of psoriasis

1996 • 138 citations

Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial

2008 • 93 citations

Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients

2008 • 63 citations

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

2007 • 59 citations

Renal function during calcitriol therapy in chronic renal failure.

1990 • 54 citations

The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics

2009 • 38 citations

Role of Vitamin D in Blood Pressure Homeostasis

2010 • 28 citations

Cited By (0)

Loading...